Idiopathic Cutaneous Pseudolymphoma Treated Successfully with Hydroxychloroquine: A Case Report and Literature Review
DOI:
https://doi.org/10.2340/actadv.v102.3201Keywords:
cutaneous pseudolymphoma, hydroxychloroquine, corticosteroidAbstract
Abstract is missing (Short Communication)
Downloads
References
Miguel D, Peckruhn M, Elsner P. Treatment of cutaneous pseudolymphoma: a systematic review. Acta Derm Venereol 2018; 98: 310-317.
https://doi.org/10.2340/00015555-2841 DOI: https://doi.org/10.2340/00015555-2841
Stoll DM. Treatment of cutaneous pseudolymphoma with hydroxychloroquine. J Am Acad Dermatol 1983; 8: 696-699.
https://doi.org/10.1016/S0190-9622(83)70082-4 DOI: https://doi.org/10.1016/S0190-9622(83)70082-4
Dragonetti E, Cianchini G, Mastrangelo L, Mellone P, Baldi A. Cutaneus pseudolymphoma: a case report. In Vivo 2004; 18: 549-551.
Moulonguet I, Ghnassia M, Molina T, Fraitag S. Miliarial-type perifollicular B-cell pseudolymphoma (lymphocytoma cutis): a misleading eruption in two women. J Cutan Pathol 2012; 39: 1016-1021.
https://doi.org/10.1111/cup.12010 DOI: https://doi.org/10.1111/cup.12010
Ye CH, Chen CJ, Chang KC, Wu YH, Chen ML, Chiu TM. Cutaneous pseudolymphoma with Langerhans cell hyperplasia - a rare case with clinical presentation mimicking malignancy and potential diagnostic pitfall. Am J Dermatopathol 2021; 43: e280-e284.
https://doi.org/10.1097/DAD.0000000000001984 DOI: https://doi.org/10.1097/DAD.0000000000001984
Joshi TP, Duvic M, Torres-Cabala CA, Tschen J. Treatment with dupilumab for refractory cutaneous B-cell pseudolymphoma. JAMA Dermatol 2022; 158: 697-699.
https://doi.org/10.1001/jamadermatol.2022.0613 DOI: https://doi.org/10.1001/jamadermatol.2022.0613
Sardana K, Sinha S, Sachdeva S. Hydroxychloroquine in dermatology and beyond: recent update. Indian Dermatol Online J 2020; 11: 453-464.
https://doi.org/10.4103/idoj.IDOJ_280_20 DOI: https://doi.org/10.4103/idoj.IDOJ_280_20
Kutzner H, Kerl H, Pfaltz MC, Kempf W. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications. Am J Surg Pathol 2009; 33: 1307-1313.
https://doi.org/10.1097/PAS.0b013e3181a6ae1e DOI: https://doi.org/10.1097/PAS.0b013e3181a6ae1e
Müller-Calleja N, Manukyan D, Canisius A, Strand D, Lackner KJ. Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase. Ann Rheum Dis 2017; 76: 891-897.
https://doi.org/10.1136/annrheumdis-2016-210012 DOI: https://doi.org/10.1136/annrheumdis-2016-210012
Published
How to Cite
License
Copyright (c) 2022 Hayato Mizuno, Shunsuke Takahagi, Satoko Morita, Akiko Kamegashira, Akio Tanaka
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
